Dollars and disease Marrying social, economic and disease dynamic perspectives for public health Nim Arinaminpathy Imperial College London.

Slides:



Advertisements
Similar presentations
TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn February 2005.
Advertisements

Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July Ties Boerma HIV Department Surveillance,
Opportunities. Shift in Perspective for Infectious Disease Control (Porter et al 1999 Health Policy and Planning 14: ) From: Disease specificity.
Tuberculosis in India: A Critical Analysis Lynette Menezes, MSW.
ARIAtlas.org. Global Impact TB causes nearly two million deaths a year, making it the world’s seventh most common cause of mortality. More than two billion.
Routine data systems related to case management Mac Otten Surveillance, Monitoring, and Evaluation Global Malaria Programme, WHO.
COUNTRY HEALTH PROFILE MYANMAR. NATIONAL HEALTH SYSTEM National Health Committee (NHC), the highest level policymaking body National Health Policy in.
Stepping up the Pace Together Dynamic Partnerships Across Community, Academic and Policy Sectors Kevin Miles - Manager of Health Programmes.
JOINT TB AND HIV PROGRAMMING AND SINGLE CONCEPT NOTE Haileyesus Getahun Global TB Programme, WHO.
TB/HIV: Impact and Opportunities Helene Gayle, MD, MPH Bill and Melinda Gates Foundation DATE, 2004.
EU and Wider Neighborhood Ukraine. EU and Wider Neighborhood Health Gap Main problem –premature adult morbidity and mortality Economic issue –loss of.
Pneumonia Sapna Bamrah, MD CDC
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Insights from economic- epidemiology Ramanan Laxminarayan Resources for the Future, Washington DC.
World Health Organization
Module 1: Course Overview. Course Objectives Teach you everything you need to know about the TB Program Describe TB the roles and responsibilities of.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Implications for Countries: Critical Issues in Service Delivery and Decision Making Dr. Yogan Pillay Deputy.
Moving forward in the diagnosis of infectious diseases in developing countries: a focus on malaria Forum organized by Fondation Mérieux & the Roll Back.
Public Health and GIS 590f: Computing in the Developing World Ruth Anderson & Yaw Anokwa
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralised care and rapid Xpert MTB/Rif test in Khayelitsha, South Africa.
Impact evaluation Evaluate new tools Translate new knowledge into policy and implementation Knowledge gap Program implementation.
A cost-effectiveness evaluation of preventive interventions for HIV-TB in Sub-Saharan Africa (Tanzania): Relevance for neurological infections Lucie Jean-Gilles.
Emerging infections and Health Protection In Scotland Looking to the future Kirsty Roy and Martin Donaghy Health Protection Scotland Scottish Government.
HIV NON-INTERVENTION: A COSTLY OPTION A NEW FRAMEWORK FOR GLOBALIZATION Jeffrey D. Sachs, PhD Director, Center for International Development Galen L. Stone.
Emerging Diseases – Ready and Waiting Aileen J Plant Curtin University of Technology 19 October, 2004 Emerging Diseases: the human health perspective.
Isoniazid preventive therapy for people living with HIV: Public health challenges and implementation issues Peter Godfrey-Faussett UNAIDS (with thanks.
 To what extent is IMCI implemented in NWP and what are the obstacles to its implementation?  What is the impact of IMCI in NWP?  What is the impact.
WHO Expert Working Group on R&D Financing Stop TB New Tools Working Groups Marcos Espinal Executive Secretary.
Unit 10. Monitoring and evaluation
TB and Poverty in The Global Plan to Stop TB Valerie Diaz, Sarah England, Knut Lönnroth, Giorgio Roscigno Stop TB Partnership Stop TB Department,
Enabling Continuity of a Public Health ARV Treatment program in a resource limited setting: The Case of the transition of the African Comprehensive HIV/AIDS.
Does the crisis make us sick? About the economic and social determinants of health Aaron Reeves University of Cambridge
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Sanghyuk Shin, PhD Department of Epidemiology UCLA Fielding School of Public Health Aug 27, 2015 Tuberculosis and HIV Co-infection: “A Deadly Syndemic”
Sources of Limited Access to Treatment High Cost of Treatment Lack of Pilot Projects Lack of Evidence Lack of Policy Lack of Demand.
100 years of living science Page 1 BSc in Global Health Paolo Vineis Helen Ward Peter Piot.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Quality Assurance for pharmaceutical products in international procurement Approach of major donors and procurers Core presentation prepared by Sophie.
TB Management: A Medical Aid Perspective presented by Dr Noluthando Nematswerani.
What is Operations Research (OR) and Implementation Research (IR)? What isn't? George Schmid World Health Organization/Centers for Disease Control and.
TB Control Measures: From development and endorsement to adoption and implementation Léopold Blanc TBS Stop TB department WHO Christy Garcia University.
Strategic Information and the Control of Tuberculosis Brian Williams and Chris Dye TB programme, Monitoring and Evaluation, WHO.
Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.
Diagnostics - More than 100 years old Drugs – Last drug 40 years old Vaccine – Nearly 90 years old Lucica Ditiu Executive Secretary, Stop TB Partnership.
TB HIV Research Perspectives of The Union Riitta Dlodlo, MD, MPH HIV Programme Coordinator The International Union Against Tuberculosis and Lung Disease.
TB infection control and prevention of XDR Group II.
Efficiency, Effectiveness, and Financial Sustainability: The Importance of Country Ownership Dr Bernhard Schwartländer UNAIDS.
STRATEGIC INFORMATION FOR ACTION IN VIET NAM 6 th Viet Nam National Scientific Conference 24 November 2015 Ha Noi, Viet Nam Amitabh Bipin SUTHAR, PharmD,
11 Laboratory Quality Improvement for clinical HIV/AIDS Services in the Uniformed Forces Mwaibako, J, Shija, L; Haverkamp, G; van den Hombergh; Katebalila,
Zindoga Mukandavire Social and Mathematical Epidemiology Group London School of Hygiene and Tropical Medicine, UK Improving health worldwide
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Coordinator of Project management Unit of Global fund and MAP projects
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Managing Pandemics Health. Health: Managing Pandemics OUTLINE What is a pandemic? Long term disease management: Malaria Sudden pandemic outbreaks: Ebola.
MODULE 3 Harm reduction advocacy
‘True Scale’ of India’s Tuberculosis Problem: 2.8 Million New Cases
Nim Arinaminpathy Imperial College London IDM Symposium, 20 Apr 2017
February 03, 2011 Daniel G. Datiko
COMBINATION PREVENTION
Nazir Ismail CTB/NICD & WHO-SRL & UP
TUBERCULOSIS, TB/HIV & MDR-TB
Common Messaging Platform
The HIV Epidemic among People who Inject Drugs
Background to ProTEST and its Role in TB/HIV Agenda-setting
South Africa: From ProTest to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
A Time of Commitments and Actions to accelerate action to End TB
33rd IUATLD World Conference on Lung Health
Strategic framework for TB/HIV
Presentation transcript:

Dollars and disease Marrying social, economic and disease dynamic perspectives for public health Nim Arinaminpathy Imperial College London

Roles of transmission models in public health Supporting healthcare delivery Informing decision-making Basic science: contributing to evidence base for policy

Careseeking (unmeasured confounders) Health systems Macroeconomic shocks National politics with borderless infections (Klepac et al, PNAS 2011) Why economics/sociological processes Individual behaviour (Funk et al, PNAS 2009) Decision-making under economic constraints (Edmunds, 200x) Implementation and logistics Market dynamics

Careseeking (unmeasured confounders) Health systems Macroeconomic shocks National politics with borderless infections (Klepac et al, PNAS 2011) Why economics/sociological processes Individual behaviour (Funk et al, PNAS 2009) Decision-making under economic constraints (Edmunds, 200x) Implementation and logistics Market dynamics

Careseeking (unmeasured confounders) Health systems Macroeconomic shocks National politics with borderless infections (Klepac et al, PNAS 2011) Why economics/sociological processes Individual behaviour (Funk et al, PNAS 2009) Decision-making under economic constraints (Edmunds, 200x) Implementation and logistics Market dynamics

Implementation: logistical/resource factors Decision trees for clinical algorithms Operations research – E.g. diagnostic tests for TB control Eg: Rao, Schellenberg & Ghani, 2013 Dowdy, Cattamanchi et al, 2011 Central laboratory Peripheral sites

Careseeking (unmeasured confounders) Health systems Macroeconomic shocks National politics with borderless infections (Klepac et al, PNAS 2011) Why economics/sociological processes Individual behaviour (Funk et al, PNAS 2009) Decision-making under economic constraints (Edmunds, 200x) Implementation and logistics Market dynamics

Diseases of poverty The ‘big three’: HIV, TB, Malaria Poverty: – Increases risk of acquiring infection – Reduces access to essential healthcare Economic factors loom large for dynamics of infection

Russia Hungary Health in financial crises: Soviet Union in the 1990s Arinaminpathy, Dye (2010) J.R.Soc.Interface Strong associations between economic changes and TB epidemiology Process vs pattern? Most recent financial crisis?

Tuberculosis today 8.7M new TB cases,1.4M deaths in M TB/HIV+ cases, 430k deaths Global Tuberculosis Report, 2012 As yet no effective TB vaccine But most TB cases are curable with 6-9 months of drug treatment.

Ecology of TB drug markets Few manufacturers of TB drugs Global demand for drugs fragmented amongst many high-burden, low- income countries Irregular supply, with drugs of uncertain quality

Ecology of TB drug markets Global Drug Facility (GDF): What impact has the GDF had, on the TB drug market? – Private-sector prices as well as in national TB programmes What might be the effects of GDF expansion? Arinaminpathy, Cordier-Lassalle, Vijay, Dye (2013) Lancet

Health systems in infectious disease dynamics Lin, Langley, Mwenda et al (2011) Int.J.Tuberc Lung Dis.

Photo credit: Peter Small

Patient trajectories and infectious periods Kapoor, Raman, Sachdeva, Satyanarayana (2012) PLoS ONE

Driving questions What are the most effective levers, at the public/private interface? How might provider incentives be structured, to minimise diagnosis and treatment delays? What effects might such interventions have on TB transmission?

Conclusions Economic factors can be an important part of the interface between infectious disease modeling and public health Health-economic implications of given interventions have played an important role in decision-making Future directions: recognising economic/sociological processes as part of the disease-dynamical system, for public health